Q3 2025 Bonesupport Holding AB Earnings Call Transcript

Oct 23, 2025 / 08:00 AM GMT

Release Date Price: $24.65 (-8.70%)

Transcript

Key Points

Positve

Bonesupport Holding AB (BOEUF) reported a strong Q3 2025 with net sales of 294 million SEK, reflecting a 24% growth compared to Q3 2024.
Sales growth at constant exchange rates was 34%, indicating strong performance despite currency fluctuations.
The company achieved an adjusted operating margin of 27%, with strong cash generation leading to a cash position of 379 million SEK.
Significant progress was made in the US market, with CerRMAG sales reaching 192 million SEK, driven by new accounts and increased usage among existing customers.
The publication of the Cerrahip study and the decision on NTAP for Sermon G in open trauma are expected to enhance market penetration and support future growth.

Negative

Currency fluctuations, particularly the depreciation of the US dollar against the Swedish crown, negatively impacted reported sales figures.
Sales in Europe were affected by seasonal volatility and ongoing disruptions in Germany, with only a 5% year-over-year growth.
The BVF product in the US showed a negative trend, with sales being 1.7% below the same quarter last year.
The UK market is recovering slowly from a substantial healthcare backlog, impacting the pace of sales growth.
Technical issues during the earnings call led to disruptions, affecting the clarity and continuity of the presentation.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BONEX.ST - Bonesupport Holding AB
Q3 2025 Bonesupport Holding AB Earnings Call
Oct 23, 2025 / 08:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome everyone to BO Supports Q3 2025 results call. My name is Thorgansk, and since September 1st, I'm the CEO of BO Support. With me here today is our CFO Joganiwanson, and together the two of us will use the next 25 minutes to guide you through the Q2 report and then open the line for any questions.

Before starting the presentation, I would like to draw your attention to the disclaimers covering any forward-looking statements that we will make today.

Next slide please.

So, let's look at the financial and operational highlights from the quarter. Q3 was another strong quarter with solid execution across the business. Net sales came in at 294 million corresponding to a growth of 24% versus Q3 2024.

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.